莱姆病疫苗在医疗保健提供者中的可接受性——美国，2018年和2022年

IF 4.5 3区医学 Q2 IMMUNOLOGY

Vaccine Pub Date : 2025-07-17 DOI:10.1016/j.vaccine.2025.127495

Taylor D. Bostic , Sarah A. Hook , Grace E. Marx

{"title":"莱姆病疫苗在医疗保健提供者中的可接受性——美国，2018年和2022年","authors":"Taylor D. Bostic , Sarah A. Hook , Grace E. Marx","doi":"10.1016/j.vaccine.2025.127495","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>A Lyme disease (LD) vaccine is expected to become available soon. We aimed to understand recent trends in healthcare provider (HCP) willingness to recommend LD vaccination.</div></div><div><h3>Methods</h3><div>Cross-sectional surveys among HCPs were conducted in 2018 and 2022. We compared willingness to recommend LD vaccination by survey year and provider characteristics.</div></div><div><h3>Results</h3><div>Among 3005 HCPs, 70.5 % reported willingness to recommend LD vaccination. This proportion was lower in 2022 than in 2018 (68 % vs 73 %; <em>p</em> < 0.01) and did not differ significantly by provider medical specialty. More HCPs in states with high LD incidence were willing to recommend the vaccine compared to HCPs in neighboring or low-incidence states (<em>p</em> < 0.01). Vaccine safety was the most frequently reported consideration for recommending LD vaccination (73 %).</div></div><div><h3>Conclusions</h3><div>HCP willingness to recommend LD vaccination decreased from 2018 to 2022. Vaccination education tailored to HCPs that address vaccine safety will be critical for a successful LD vaccination program.</div></div>","PeriodicalId":23491,"journal":{"name":"Vaccine","volume":"62 ","pages":"Article 127495"},"PeriodicalIF":4.5000,"publicationDate":"2025-07-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Lyme disease vaccine acceptability among healthcare providers ― United States, 2018 and 2022\",\"authors\":\"Taylor D. Bostic , Sarah A. Hook , Grace E. Marx\",\"doi\":\"10.1016/j.vaccine.2025.127495\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Background</h3><div>A Lyme disease (LD) vaccine is expected to become available soon. We aimed to understand recent trends in healthcare provider (HCP) willingness to recommend LD vaccination.</div></div><div><h3>Methods</h3><div>Cross-sectional surveys among HCPs were conducted in 2018 and 2022. We compared willingness to recommend LD vaccination by survey year and provider characteristics.</div></div><div><h3>Results</h3><div>Among 3005 HCPs, 70.5 % reported willingness to recommend LD vaccination. This proportion was lower in 2022 than in 2018 (68 % vs 73 %; <em>p</em> < 0.01) and did not differ significantly by provider medical specialty. More HCPs in states with high LD incidence were willing to recommend the vaccine compared to HCPs in neighboring or low-incidence states (<em>p</em> < 0.01). Vaccine safety was the most frequently reported consideration for recommending LD vaccination (73 %).</div></div><div><h3>Conclusions</h3><div>HCP willingness to recommend LD vaccination decreased from 2018 to 2022. Vaccination education tailored to HCPs that address vaccine safety will be critical for a successful LD vaccination program.</div></div>\",\"PeriodicalId\":23491,\"journal\":{\"name\":\"Vaccine\",\"volume\":\"62 \",\"pages\":\"Article 127495\"},\"PeriodicalIF\":4.5000,\"publicationDate\":\"2025-07-17\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Vaccine\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0264410X25007923\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"IMMUNOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Vaccine","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0264410X25007923","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"IMMUNOLOGY","Score":null,"Total":0}

引用次数: 0

摘要

莱姆病（LD）疫苗预计将很快上市。我们旨在了解卫生保健提供者（HCP）推荐LD疫苗接种意愿的最新趋势。方法在2018年和2022年对卫生专业人员进行横断面调查。我们通过调查年份和提供者特征比较推荐LD疫苗接种的意愿。结果3005名HCPs中，70.5%报告愿意推荐接种LD疫苗。2022年这一比例低于2018年(68%比73%；p & lt;0.01)，不同提供者的医学专业差异不显著。与邻近或低发病率州的HCPs相比，LD高发病率州的HCPs更愿意推荐疫苗(p <；0.01)。疫苗安全性是推荐LD疫苗接种的最常见考虑因素（73%）。结论2018 ~ 2022年shcp推荐接种LD疫苗的意愿有所下降。针对解决疫苗安全问题的卫生保健提供者量身定制的疫苗接种教育对于成功的LD疫苗接种规划至关重要。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Lyme disease vaccine acceptability among healthcare providers ― United States, 2018 and 2022

Background

A Lyme disease (LD) vaccine is expected to become available soon. We aimed to understand recent trends in healthcare provider (HCP) willingness to recommend LD vaccination.

Methods

Cross-sectional surveys among HCPs were conducted in 2018 and 2022. We compared willingness to recommend LD vaccination by survey year and provider characteristics.

Results

Among 3005 HCPs, 70.5 % reported willingness to recommend LD vaccination. This proportion was lower in 2022 than in 2018 (68 % vs 73 %; p < 0.01) and did not differ significantly by provider medical specialty. More HCPs in states with high LD incidence were willing to recommend the vaccine compared to HCPs in neighboring or low-incidence states (p < 0.01). Vaccine safety was the most frequently reported consideration for recommending LD vaccination (73 %).

Conclusions

HCP willingness to recommend LD vaccination decreased from 2018 to 2022. Vaccination education tailored to HCPs that address vaccine safety will be critical for a successful LD vaccination program.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Vaccine 医学-免疫学

CiteScore

8.70

自引率

5.50%

发文量

992

审稿时长

131 days

期刊介绍： Vaccine is unique in publishing the highest quality science across all disciplines relevant to the field of vaccinology - all original article submissions across basic and clinical research, vaccine manufacturing, history, public policy, behavioral science and ethics, social sciences, safety, and many other related areas are welcomed. The submission categories as given in the Guide for Authors indicate where we receive the most papers. Papers outside these major areas are also welcome and authors are encouraged to contact us with specific questions.